Supreme Court to review $21M verdict for NH woman injured by generic drug
The court agreed to review a bid by Mutual Pharmaceutical Co to overturn a $21 million jury award to Karen Bartlett, a New Hampshire woman who had taken its generic non-steroidal anti-inflammatory drug sulindac for shoulder pain.
LATEST NEW HAMPSHIRE ANGLE
Unions endorse pipeline through NH
The accidental lobster farmers